DK2101792T3 - Anvendelse af carrageenan til behandling af rhinovirus-infektioner - Google Patents

Anvendelse af carrageenan til behandling af rhinovirus-infektioner

Info

Publication number: DK2101792T3
Authority: DK; Denmark
Prior art keywords: carrageenan; rhinovirus infections; treat rhinovirus; treat; infections
Prior art date: 2006-12-05

Application number

DK07856354.1T

Other languages

English (en)

Inventor

Andreas Grassauer

Eva Prieschl-Grassauer

Christiane Meier

Alexander Pretsch

Original Assignee

Marinomed Biotechnologie Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-05

Filing date

2007-12-04

Publication date

2010-07-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39383268&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2101792(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-12-05 Priority claimed from EP06450176A external-priority patent/EP1930015A1/en

2006-12-05 Priority claimed from US11/567,078 external-priority patent/US20080131454A1/en

2007-12-04 Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh

2010-07-26 Application granted granted Critical

2010-07-26 Publication of DK2101792T3 publication Critical patent/DK2101792T3/da

Links

206010061494 Rhinovirus infection Diseases 0.000 title abstract 2
229940113118 carrageenan Drugs 0.000 title 1
235000010418 carrageenan Nutrition 0.000 title 1
229920001525 carrageenan Polymers 0.000 title 1
239000000679 carrageenan Substances 0.000 title 1
UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 title 1
230000000840 anti-viral effect Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Dermatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Paper (AREA)

DK07856354.1T 2006-12-05 2007-12-04 Anvendelse af carrageenan til behandling af rhinovirus-infektioner DK2101792T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP06450176A EP1930015A1 (en)	2006-12-05	2006-12-05	Use of carrageenan for treating rhinovirus infections
US11/567,078 US20080131454A1 (en)	2006-12-05	2006-12-05	Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
PCT/EP2007/010512 WO2008067982A2 (en)	2006-12-05	2007-12-04	Use of carrageenan for treating rhinovirus infections

Publications (1)

Publication Number	Publication Date
DK2101792T3 true DK2101792T3 (da)	2010-07-26

Family

ID=39383268

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK07856354.1T DK2101792T3 (da)	2006-12-05	2007-12-04	Anvendelse af carrageenan til behandling af rhinovirus-infektioner

Country Status (23)

Country	Link
EP (1)	EP2101792B1 (da)
JP (1)	JP5470047B2 (da)
KR (1)	KR101437708B1 (da)
CN (1)	CN101678040B (da)
AT (1)	ATE462438T1 (da)
AU (1)	AU2007327934B2 (da)
BR (1)	BRPI0720054A2 (da)
CA (1)	CA2671317C (da)
CY (1)	CY1110658T1 (da)
DE (1)	DE602007005697D1 (da)
DK (1)	DK2101792T3 (da)
EA (1)	EA015930B1 (da)
ES (1)	ES2343701T3 (da)
IL (1)	IL198810A (da)
MA (1)	MA31145B1 (da)
MX (1)	MX2009005838A (da)
NO (1)	NO342681B1 (da)
NZ (1)	NZ577063A (da)
PL (1)	PL2101792T3 (da)
PT (1)	PT2101792E (da)
SI (1)	SI2101792T1 (da)
TN (1)	TN2009000211A1 (da)
WO (1)	WO2008067982A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2303287T3 (da) *	2008-07-01	2014-02-17	Marinomed Biotechnologie Gmbh	Antiallergiske marine biopolymerer
JP5702526B2 (ja)	2009-04-30	2015-04-15	Ｅｓファイバービジョンズ株式会社	抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
AU2010335594B2 (en)	2009-12-22	2015-05-21	Marinomed Biotechnologie Gmbh	Synergistic antiviral composition and use thereof
JP5900030B2 (ja)	2011-03-08	2016-04-06	凸版印刷株式会社	防湿容器
PT2898888T (pt) *	2014-01-22	2019-07-16	Visufarma B V	Composição que compreende iota-carragenina contra conjuntivite viral
AU2016293004B2 (en)	2015-07-14	2021-05-06	Unither Pharmaceuticals	Stuffy nose deblocking composition having antiviral activity
UA118192C2 (uk) *	2015-10-22	2018-12-10	Юрій Захарович Толчеєв	Противірусна фармацевтична композиція
KR102316819B1 (ko) *	2018-04-20	2021-10-25	한미약품 주식회사	카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
KR101995376B1 (ko) *	2018-08-20	2019-07-02	한미약품 주식회사	카라기난을 유효성분으로 포함하는 항-바이러스 조성물
GB2579600B (en)	2018-12-05	2023-07-05	Byotrol Plc	Anti-viral composition
CN111437270A (zh) *	2020-04-24	2020-07-24	瑞希(重庆)生物科技有限公司	一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法
JP7821168B2 (ja)	2020-09-08	2026-02-26	アルタミラメディカ，アーゲー	感染を防止するための組成物
KR102720037B1 (ko) *	2021-12-21	2024-10-22	(주)메디코어	비강 세정제 조성물 및 그 제조방법
EP4784132A1 (en)	2023-09-26	2026-08-05	MetrioPharm AG	5-amino-2,3-dihydro-1,4-phthalazinedione for the treatment of infections with an rna virus
CN122270289A (zh) *	2023-11-30	2026-06-23	斯特拉斯堡大学	同时具有抗细菌和抗病毒特性的生物材料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2263643T3 (es)	2000-07-28	2006-12-16	Immupharm Aps	Uso de hidroxietilrutosidos para el tratamiento de los sintomas del r esfriado comun, de la fiebre de heno y de infecciones relacionadas con el tacto respiratorio.
US6953483B2 (en) *	2002-03-05	2005-10-11	Litke Kenneth S	Aloe vera processed leather and leather gloves, garments, shoes and sandals made from aloe vera processed leather and a process for making aloe vera processed leather
AU2003245252A1 (en) *	2002-04-30	2003-11-17	Fmc Corporation	Carrageenan based antimicrobial compositions
CN1194981C (zh) *	2002-07-22	2005-03-30	青岛海洋大学	卡拉胶低聚糖的制备方法
CN100435805C (zh) *	2003-05-26	2008-11-26	福州大学	多糖硫酸酯作为制备抗流感病毒药物的应用
US20050009782A1 (en) *	2003-07-09	2005-01-13	Comper Wayne D.	Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
WO2006003521A1 (en) *	2004-02-06	2006-01-12	Monash University	High dose, short interval use of sulfated polysaccharides for the treatment of infections
DE202005014019U1 (de) *	2005-09-05	2005-11-24	G. Pohl-Boskamp Gmbh & Co. Kg	Zubereitung zum Ersatz von Speichelflüssigkeit und zur Pflege bei Trockenheit der Mund- und Rachenschleimhäute
ITRM20060115A1 (it) *	2006-03-06	2006-06-05	Paolo Ottier	Guanto costituito da tre strati sovrapposti di poliuretano di cui due a tenuta stagna contenenti olio lubrificante per la parpazione del seno femminile
DE102006031812A1 (de)	2006-07-07	2008-01-17	Leoni Ag	Sensorsystem und Sensorelement

2007
- 2007-12-04 SI SI200730256T patent/SI2101792T1/sl unknown
- 2007-12-04 CN CN2007800448779A patent/CN101678040B/zh active Active
- 2007-12-04 BR BRPI0720054-4A patent/BRPI0720054A2/pt not_active Application Discontinuation
- 2007-12-04 NZ NZ577063A patent/NZ577063A/en unknown
- 2007-12-04 KR KR1020097010412A patent/KR101437708B1/ko active Active
- 2007-12-04 MX MX2009005838A patent/MX2009005838A/es active IP Right Grant
- 2007-12-04 AT AT07856354T patent/ATE462438T1/de active
- 2007-12-04 ES ES07856354T patent/ES2343701T3/es active Active
- 2007-12-04 DK DK07856354.1T patent/DK2101792T3/da active
- 2007-12-04 EA EA200970529A patent/EA015930B1/ru not_active IP Right Cessation
- 2007-12-04 AU AU2007327934A patent/AU2007327934B2/en active Active
- 2007-12-04 JP JP2009539654A patent/JP5470047B2/ja active Active
- 2007-12-04 EP EP07856354A patent/EP2101792B1/en active Active
- 2007-12-04 DE DE602007005697T patent/DE602007005697D1/de active Active
- 2007-12-04 PT PT07856354T patent/PT2101792E/pt unknown
- 2007-12-04 WO PCT/EP2007/010512 patent/WO2008067982A2/en not_active Ceased
- 2007-12-04 CA CA2671317A patent/CA2671317C/en active Active
- 2007-12-04 PL PL07856354T patent/PL2101792T3/pl unknown
2009
- 2009-05-19 IL IL198810A patent/IL198810A/en active IP Right Grant
- 2009-05-20 NO NO20091955A patent/NO342681B1/no unknown
- 2009-05-29 TN TNP2009000211A patent/TN2009000211A1/fr unknown
- 2009-07-02 MA MA32065A patent/MA31145B1/fr unknown
2010
- 2010-06-25 CY CY20101100586T patent/CY1110658T1/el unknown

Also Published As

Publication number	Publication date
NO20091955L (no)	2009-09-04
SI2101792T1 (sl)	2010-08-31
MA31145B1 (fr)	2010-02-01
IL198810A (en)	2013-03-24
CA2671317C (en)	2015-03-17
NO342681B1 (no)	2018-07-02
EP2101792A2 (en)	2009-09-23
ATE462438T1 (de)	2010-04-15
CY1110658T1 (el)	2015-06-10
WO2008067982A3 (en)	2009-04-16
CN101678040B (zh)	2012-10-03
MX2009005838A (es)	2009-06-16
PL2101792T3 (pl)	2010-11-30
NZ577063A (en)	2011-05-27
HK1141980A1 (en)	2010-11-26
DE602007005697D1 (de)	2010-05-12
KR20090096598A (ko)	2009-09-11
WO2008067982A2 (en)	2008-06-12
BRPI0720054A2 (pt)	2013-12-17
CN101678040A (zh)	2010-03-24
TN2009000211A1 (en)	2010-10-18
KR101437708B1 (ko)	2014-09-03
EA200970529A1 (ru)	2009-12-30
AU2007327934B2 (en)	2013-04-18
EA015930B1 (ru)	2011-12-30
IL198810A0 (en)	2010-02-17
ES2343701T3 (es)	2010-08-06
JP5470047B2 (ja)	2014-04-16
EP2101792B1 (en)	2010-03-31
CA2671317A1 (en)	2008-06-12
PT2101792E (pt)	2010-06-25
AU2007327934A1 (en)	2008-06-12
JP2010512307A (ja)	2010-04-22

Publication	Publication Date	Title
ATE462438T1 (de)	2010-04-15	Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
CL2011000691A1 (es)	2011-07-29	Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
BR112012010270A2 (pt)	2016-11-29	mentisulfonilmetano (msm) para tratamento de micro-organismos resistentes a fármaco
MA33803B1 (fr)	2012-12-03	Inhibiteur de bromodomaine de benzodiazépine
DK1984357T3 (da)	2014-01-13	2,4-pyrimidindiaminforbindelser til behandling eller forebyggelse af autoimmunsygdomme
UA118149C2 (uk)	2018-11-26	Інгібітор jak
DK2474321T3 (da)	2019-06-03	Sammensætninger til behandling af collagenmedierede sygdomme
EA201001847A1 (ru)	2011-08-30	Соединения и композиции, применяемые для лечения малярии
EA201170832A1 (ru)	2011-12-30	Пуриновые соединения
EA200801997A1 (ru)	2009-04-28	Новые соединения
EA201200098A1 (ru)	2012-07-30	Конденсированные имидазолы и содержащие их композиции, предназначенные для лечения паразитарных заболеваний, таких как, например, малярия
MX2009008495A (es)	2009-08-20	Novedosos analogos de nucleosidos para el tratamiento de infecciones virales.
CL2011000165A1 (es)	2011-06-17	Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento y/o la prevencion del cancer, infecciones, enfermedades inflamatorias y autoinmunes.
MA32841B1 (fr)	2011-11-01	Composés de cycloundeca depsipeptides et leur utilisation comme médicament
CL2008002384A1 (es)	2009-07-17	Compuestos derivados de quinoliniloxipiperidina y pirrolidina, composicion farmaceutica, combinacion farmaceutica, util para el tratamiento de enfermedades inflamatorias y/o alergicas del tracto respiratorio.
UA107346C2 (en)	2014-12-25	Use of nifuratel to treat infections caused by atopobium species
JO2999B1 (ar)	2016-09-05	مركب ثلاثي حلقي و استخدامه الدوائي
CL2011002625A1 (es)	2012-04-20	Compuestos derivados de 3-(piridin-3-il-etinil)-piridina; preparaciones farmaceuticas que los contienen; y su uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunes.
ATE475424T1 (de)	2010-08-15	Cellulosesulfat zur behandlung von rhinovirus- infektionen
UA94781C2 (ru)	2011-06-10	Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
ATE474574T1 (de)	2010-08-15	Imidazoazephinonverbindungen
EA200702336A1 (ru)	2008-04-28	ПРИМЕНЕНИЕ 24-норУДХК
ATE380188T1 (de)	2007-12-15	Substituierte chinolone
FR2905600B1 (fr)	2010-01-15	Traitement des vertiges par l'acetyl-l-leucine.
DE602007009413D1 (de)	2010-11-04	Sitamaquintosylat zur behandlung von leishmaniase